servier.com valid
Clinical Trials
For agents: Servier pharmaceutical company's clinical trials section listing studies such as IDH1 cholangiocarcinoma and other drug trials, with privacy and terms pages.
clinical trialsoncologypharmaceutical researchstudy listingsdrug development
- Authority
- 56 reach 14 · trust 10 · quality 17 · freshness 15
- Tier
- listed
- llms.txt
- https://clinicaltrials.servier.com/llms.txt
- Sections
- 2
- Links
- 11
- Size
- 2777 bytes
- Popularity rank
- #43841
- Registered
- 1998-12-29
- Country
- Ireland Hosting inference
- Hosting country
- Ireland Hosting inference
- Country evidence
- No published address evidence collected yet
- Categories
- Healthcare · Science and research
- For agents
- Documentation: developer or product docs worth reading, nothing to call
- Inferred actions
- Search content Read documentation About these labels
- Audience
- mixed · agents can: search content, read docs · en
- First seen
- 2026-10-18T15:08:54.699Z
- Last checked
- 2026-10-23T23:49:01.674Z
- Badge
Their llms.txt
The beginning of the file, from our validated copy saved 2026-10-23T23:49:00.064Z. Cached copy · Source on servier.com
Generated by Yoast SEO v26.5, this is an llms.txt file, meant for consumption by LLMs.
The XML sitemap of this website can be found by following [this link](https://clinicaltrials.servier.com/sitemap_index.xml).
# Clinical Trials
## Pages
- [Politique de confidentialité](https://clinicaltrials.servier.com/fr/declaration-de-confidentialite/)
- [Privacy Policy:](https://clinicaltrials.servier.com/privacy-notice/)
- [Conditions d'utilisation](https://clinicaltrials.servier.com/fr/conditions-dutilisation/)
- [Terms of use](https://clinicaltrials.servier.com/terms-of-use/)
- [Nos engagements en matière de R\&D](https://clinicaltrials.servier.com/fr/nos-engagements-en-matiere-de-rd/)
## Study
- [Combinaison d'Ivosidenib, Nivolumab et Ipilimumab chez des sujets précédemment traités atteints de cholangiocarcinome mutant IDH1 non résécable ou métastatique\.](https://clinicaltrials.servier.com/fr/trial/combinaison-divosidenib-nivolumab-et-ipilimumab-chez-des-sujets-precedemment-traites-atteints-de-cholangiocarcinome-mutant-idh1-non-resecable-ou-metastatique/)
- [A study to evaluate the efficacy and safety of gliclazide MR in patients with type 2 diabetes inadequately controlled with dapagliflozin with or without metformin](https://clinicaltrials.servier.com/trial/a-study-to-evaluate-the-efficacy-and-safety-of-gliclazide-mr-in-patients-with-type-2-diabetes-inadequately-controlled-with-dapagliflozin-with-or-without-metformin/)
- [A Phase Ib/II first\-in\-human, multicentre, open\-label, multiple ascending dose study of S230815 in paediatric participants with KCNT1\-related Developmental and Epileptic Encephalopathy](https://clinicaltrials.servier.com/trial/a-phase-ib-ii-first-in-human-multicentre-open-label-multiple-ascending-dose-study-of-s230815-in-paediatric-participants-with-kcnt1-related-developmental-and-epileptic-encephalopathy/)
- [Première étude chez l’homme de phase Ib/II, multicentrique, en ouvert, à doses multiples croissantes, portant sur le S230815 chez des participants pédiatriques atteints d’encéphalopathie épileptique et développementale liée à KCNT\-1](https://clinicaltrials.servier.com/fr/trial/premiere-etude-chez-lhomme-de-phase-ib-ii-multicentrique-en-ouvert-a-doses-multiples-croissantes-portant-sur-le-s230815-chez-des-participants-pediatriques-atteints-dencephalopath/)
- [Multiple\-Dose Study on the Bioequivalence of One Tablet of Gliclazide MR 120 mg \(S005190\) and Two Tablets of Gliclazide MR 60 mg \(Diaprel® MR\) in Healthy Participants under Fed Conditions\.](https://clinicaltrials.servier.com/trial/multiple-dose-study-on-the-bioequivalence-of-one-tablet-of-gliclazide-mr-120-mg-s005190-and-two-tablets-of-gliclazide-mr-60-mg-diaprel-mr-in-healthy-participants-under-fed-conditions/)
Related sites
Find similar publishers by meaning →
Other listed sites in Healthcare. See the whole category →
| Domain | Title | Category | Country | Authority | llms.txt | llms-full.txt | Save |
|---|---|---|---|---|---|---|---|
| opentext.com | OpenText | documentation Cybersecurity Finance and payments +4 | CA | 70 | ✓ | ✓ | |
| siemens.com | Siemens | transactional Healthcare Industry and manufacturing | US | 69 | ✓ | ||
| additudemag.com | ADDitude | documentation Media Healthcare | — | 67 | ✓ | ✓ | |
| medicalxpress.com | Medical Xpress | documentation Healthcare Media +1 | US | 67 | ✓ | ||
| headspace.com | Mental Health App for Meditation & Sleep - Headspace | transactional Healthcare | — | 66 | ✓ | ||
| psicologiaymente.com | Psicología y Mente | informational Healthcare Media | — | 66 | ✓ | ✓ | |
| asclepiuswellness.com | Asclepius Wellness Private Limited (AWPL) | documentation Healthcare | IN | 65 | ✓ | ✓ | |
| flywire.com | Flywire | documentation Finance and payments Healthcare | US | 65 | ✓ | ✓ |
Machine-readable: GET /v1/resolve?q=servier.com · GET /v1/domain/servier.com · this page as Accept: application/json or text/markdown · MCP lookup_domain
Automatically discovered from public files. Inclusion does not imply endorsement or publisher participation.
Own or manage this website?
If you own or manage servier.com, you can update its listing and review file health, discovery activity and score history.
Manage this listing — optional
What verification unlocks
See how your site is discovered—and control what agents see.
- See your website in the map
Review your indexed topics, nearby publishers sharing headings, measured listing exposure and map snapshots in a private report for your website.
- Control what agents see
Edit your listing description, tags, public contact details and additional llms.txt paths. Publish your terms for automated access, attribution and pricing.
- Make your profile eligible for search
A valid, listed, unblocked, verified profile can appear in our publisher sitemap and become eligible for search-engine visibility. Search engines decide what to index and rank.
- Appear in our llms-full.txt
Eligible verified publishers are listed by name, with their file links and summaries, in the service overview agents can read.
Free. No account registration, backlink or payment required. Public discovery remains available without verification.
Let your coding agent verify it
If your coding agent is authorized to manage this website, paste these instructions into it.
Claim my listing on Agent Web Map for servier.com:
1. POST https://agentwebmap.com/v1/sites/servier.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://servier.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/servier.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/servier.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verifyCorrections or removal requests: contact the directory.